- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 235/12 - Radicals substituted by oxygen atoms
Patent holdings for IPC class C07D 235/12
Total number of patents in this class: 189
10-year publication summary
|
9
|
9
|
20
|
11
|
11
|
10
|
9
|
12
|
4
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ecolab USA Inc. | 5813 |
12 |
| Nippon Shinyaku Co., Ltd. | 325 |
8 |
| Epizyme, Inc. | 360 |
6 |
| FUJIFILM Corporation | 30594 |
5 |
| Jiangsu Hengrui Medicine Co., Ltd. | 686 |
5 |
| F. Hoffmann-La Roche AG | 7808 |
4 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 719 |
4 |
| UCB Biopharma SPRL | 332 |
4 |
| University of Washington through its Center for Commercialization | 505 |
4 |
| Yale University | 2557 |
4 |
| Janssen Pharmaceutica N.V. | 3160 |
3 |
| Allergan, Inc. | 2157 |
3 |
| Astellas Pharma Inc. | 1039 |
3 |
| Glenmark Pharmaceuticals S.A. | 115 |
3 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3275 |
3 |
| The Wistar Institute of Anatomy and Biology | 484 |
3 |
| Novartis AG | 10173 |
2 |
| Genentech, Inc. | 4114 |
2 |
| Centre National de La Recherche Scientifique | 11059 |
2 |
| Commissariat à l'énergie atomique et aux energies alternatives | 11127 |
2 |
| Other owners | 107 |